性能参数 |
|||
产品名称 |
CPI-203 |
||
规格 |
1mg 5mg |
||
货号 |
GOY-Y2151 |
||
含量 |
>98.00% |
||
CAS |
1446144-04-2 |
||
别名 |
|
|
|
化学名 |
(S)-2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetamide |
分子式 |
C19H18ClN5OS |
分子量 |
分子 399.9 |
溶解度 |
≥ 40mg/mL in DMSO |
储存条件 |
Store at -20°C |
General tips |
|
用途 |
仅供科研 |
价格 |
电询 |
|
|||
详细内容 |
As an inhibitor of BET proteins, CPI-203 inhibits BRD4 in vitro and in cells. It inhibits the specific Ser2 phosphorylation of both endogenous BRD4 and exogenous mutant BRD4 (BRD4 FEE-AAA) in vivo, thus blocking the recruitment of BRD4 to chromatin. CPI-203 is shown to suppress cell growth of 9 MCL cell lines. And in REC-1 cells, treatment of CPI-203 causes the effects of IRF4 expression. CPI-203 marginally activates the apoptotic program in these cells. The CPI-203-lenalidomide combination is reported to be a promising strategy in MCL cases refractory to proteasome inhibition [1, 2]. References: [1] Moros A, Rodríguez V, Saborit-Villarroya I, Montraveta A, Balsas P, Sandy P, Martínez A, Wiestner A, Normant E, Campo E, Pérez-Galán P, Colomer D, Roué G. Synergistic antitumor activity of lenalidomide with the BET bromodomain inhibitor CPI203 in bortezomib-resistant mantle cell lymphoma. Leukemia. 2014 Mar 18. [2] Devaiah BN, Lewis BA, Cherman N, Hewitt MC, Albrecht BK, Robey PG, Ozato K, Sims RJ 3rd, Singer DS. BRD4 is an atypical kinase that phosphorylates serine2 of the RNA polymerase II carboxy-terminal domain. Proc Natl Acad Sci U S A. 2012 May 1;109(18):6927-32. |
公司正在销售的产品:
丙烯酸丁酯(BA) GCS,≥99.5% (GC) L-精氨酸 98% 丙烯酸丁酯 AR,99% L-丙氨酸 99% 丙烯酸丁酯 CP,98% L-天门冬氨酸 99% 丙烯酸丁酯 分析标准品,>99.5% (GC) L-天门冬氨酸 用于细胞或植物细胞培养, ≥99% (T) 丙烯酸异辛酯 >99.0%(GC) L-精氨酸 非动物源,EP, JP, USP ;用于细胞培养,98.5 to 101.0 丙烯酸异辛酯 分析标准品,≥99.5% (GC) L-谷氨酸 99% |
FAAH inhibitor 15mg 10mg 50mg 100mg>95.00%Cas No. 326866-17-5C24H23N3O3S3 Fluvastatin (sodium salt hydrate)10 mg 25 mg 50 mg 100 mg>95.00%Cas No. N/AC24H25FNO4.Na [XH2O] FKGK 185mg 10mg 25mg 50mg>95.00%Cas No. 1071001-09-6C16H15F3O Fondaparinux (sodium salt)1mg 5mg 10mg 25mg>95.00%Cas No. 114870-03-0C31H43N3O49S8?10Na GK187500μg 1mg 5mg 10mg>95.00%Cas No. 1071001-50-7C14H15F5O2 Gentisein100 mg 250 mg 500 mg 1 g>95.00%Cas No. 529-49-7C13H8O5 |
传真号码:021-39596320 021-39921927
QQ: 3004918891 3004905818 3004901493
移动电话:18321818584 15026555973
地址:上海松江新砖公路1155号
产品均为实验试剂,仅供科研实验使用,非药品、非食品、不可用于动物及人体!